(Vaccine Label Examples)

Staff can easily become confused about vaccines within the storage unit because there are so many brands and formulations available. Labeling the area where vaccines are stored can help staff quickly locate and choose the correct vaccine with the goal of preventing a vaccine administration error. Depending on how vaccines are organized within the storage unit, labels can be placed on containers or bins or directly attached to shelves where vaccines are placed. Other helpful strategies to prevent vaccine administration errors include color-coding labels (e.g., one color for pediatric and another for adult vaccines) and providing additional information such as age indications or other information unique to the vaccine.

In addition, some vaccines must be reconstituted before administration. These vaccines have two components—a lyophilized vaccine and a diluent that must be mixed together. **The lyophilized vaccine should only be reconstituted or mixed using the diluent supplied by the manufacturer**. Consider posting reminders or labeling vaccines to remind staff to reconstitute certain vaccines prior to administration.

The following labels are examples that may be used to help organize vaccines. Labels are based on recommendations from the Advisory Committee on Immunization Practices (ACIP) and may include indications different from those of the Food and Drug Administration. The Centers for Disease Control and Prevention (CDC) also recommends vaccines be stored in the original packaging to protect the contents from light, to help maintain the recommended temperature range, and to help prevent administration errors.

Note: Some vaccine preparations are being transitioned from vials and prefilled syringes that contain natural rubber latex to vials and prefilled syringes that are not made with natural rubber latex. Read the package insert that accompanies the product to check for the presence of natural rubber latex.

      Updated 10/17/2023

Dengue

**DENGVAXIA**

**(Live Dengue Vaccine)**

· **Lyophilized Powder Vaccine Antigen Vial**

· **Saline Diluent Vial**

**Ages:		9 years through 16 years (with laboratory-confirmed previous dengue infection and living in dengue-endemic areas)**

**Dosage: 0.5 mL each, 6 months apart (at 0, 6, and 12) Route: Subcutaneous (SUBCUT) injection**

**Protect From Light Do Not Freeze**

**Reconstitute ONLY with 0.6 mL of manufacturer-supplied 0.9⁒ saline diluent Withdraw 0.5 mL for administration**

**After reconstitution, administer immediately or store at 2°C to 8°C (36°F to 46°F) and use within 30 minutes**

 (Ages:DTaP (Daptacel)6 weeks through 6 yearsUse for: Any dose in the seriesRoute:Intramuscular (IM) injection)	 (Ages:DTaP-IPV (Kinrix)4 years through 6 yearsUse for: DTaP dose #5IPV dose #4Do NOT use for DTaP doses 1 through 4 OR IPV doses 1 through 3Route:Intramuscular (IM) injection)

 (Ages:DTaP (Infanrix)6 weeks through 6 yearsUse for: Any dose in the seriesRoute:Intramuscular (IM) injection) (DTaP-IPV-HepB (Pediarix)Ages:6 weeks through 6 yearsUse for:DTaP and IPV: Doses #1, #2, and/or #3 HepB: Any dose in the seriesDo NOT use for HepB birth doseRoute:Intramuscular (IM) injection)

 (Diphtheria- and Tetanus-Toxoid- and acellular Pertussis-Containing Vaccines)

 (DTaP-IPV-Hib (Pentacel)Ages:6 weeks through 4 yearsUse for:DTaP and IPV: Doses #1, #2, #3, and/or #4Hib: Any dose in the seriesRoute:Intramuscular (IM) injectionReconstitute Hib powder ONLY with manufacturer-supplied DTaP-IPV liquid diluentUse immediately after reconstitutionDo NOT administer DTaP-IPV w/o Hib)	 (DTaP-IPV-HepB-Hib (Vaxelis)Ages:6 weeks through 4 yearsUse for:DTaP and IPV: Doses #1, #2, and/or#3Hep B: Any dose in the series(Do NOT use for HepB birth dose)Hib: Any dose in the seriesRoute:Intramuscular (IM) injection)

 (Ages:DTaP-IPV (Quadracel)4 years through 6 yearsUse for: DTaP dose #5IPV dose #4 or #5Do NOT use for DTaP doses 1 through 4 OR IPV doses 1 through 3Route:Intramuscular (IM) injection)

 (Ages:Hib (ActHIB)6 weeks through 4 yearsUse for: Any dose in the seriesRoute:Intramuscular (IM) injectionReconstitute Hib powder ONLY with manufacturer- supplied 0.4% sodium chloride diluentBeyond Use Time: If not used immediately after reconstitution, store at 2°C to 8°C (36°F to 46°F) and discard if not used within 24 hours.Shake well prior to administration.)	 (Ages:Hib (PedvaxHIB)6 weeks through 4 yearsUse for: Any dose in the seriesRoute:Intramuscular (IM) injection)

 (Ages:Hib (Hiberix)6 weeks through 4 yearsUse for: Any dose in the seriesRoute:Intramuscular (IM) injectionReconstitute Hib powder ONLY with manufacturer- supplied 0.9% sodium chloride diluentBeyond Use Time: If not used immediately after reconstitution, store at 2°C to 8°C (36°F to 46°F) and discard if not used within 24 hours. Shake well prior to administration.)

 (Haemophilus influenzae type b-Containing Vaccines)

 (HepA (Havrix)-Pediatric FormulationAges:12 months through 18 yearsUse for: Any dose in the seriesRoute:Intramuscular (IM) injection)	 (HepB (Engerix-B)-Pediatric FormulationAges:Birth through 19 yearsUse for: Any dose in the seriesRoute:Intramuscular (IM) injection)

 (HepA (Vaqta)-Pediatric FormulationAges:12 months through 18 yearsUse for: Any dose in the seriesRoute:Intramuscular (IM) injection) (HepB (Recombivax HB)-PediatricFormulationAges:Birth through 19 yearsUse for: Any dose in the seriesRoute:Intramuscular (IM) injection)

 (Hepatitis Vaccines)

 (HepA (Havrix)-Adult FormulationAges:19 years and olderUse for: Any dose in the seriesRoute:Intramuscular (IM) injection)	 (HepB (Engerix-B)-Adult FormulationAges:20 years and olderUse for: Any dose in the seriesRoute:Intramuscular (IM) injection)

 (HepA (Vaqta)-Adult FormulationAges:19 years and olderUse for: Any dose in the seriesRoute:Intramuscular (IM) injection) (HepB (Recombivax HB)-AdultFormulationAges:Use for:20 years and olderAny dose in the seriesAlternate Adolescent Schedule for 11- through 15 -year olds:Two 1 mL doses 4 to 6 months apartRoute:Intramuscular (IM) injection)

 (Ages:HepB (Heplisav-B)18 years and olderUse for: Any dose in the series (two 0.5 mL              doses 1 month apart)Route:Intramuscular (IM) injection)	 (Ages:HepA-HepB (Twinrix)18 years and olderContains: HepA = Pediatric dosageHepB = Adult dosageSchedule: 0, 1, and 6 monthsAlternate Schedule: 0, 7, and 21 to 30 days, followed by booster at 12 monthsRoute:Intramuscular (IM) injection)

**Ages:**

**HepB (PreHevbrio)**

18 years and older

**Use for:**Any dose in the series

**Route:**

Intramuscular (IM) injection

 (9vHPV (Gardasil 9)Ages: 9 years through 45 yearsRecommended ages: 11 years or 12 yearsCatch-up ages: 13 years through 26 yearsShared clinical decision-making ages: 27 through 45 yearsRoute: Intramuscular (IM) injection)

 (Human Papillomavirus Vaccines)

# Measles, Mumps, Rubella Vaccine

 (Ages:MMR (M-M-R II)12 months and olderUse for: Any dose in the seriesRoute:Subcutaneous (subcut) injectionReconstitute MMR powder ONLY with manufacturer-supplied sterile water diluentBeyond Use Time: If not used immediately after reconstitution, store in vaccine vial in dark place at 2°C to 8°C (36°F to 46°F) and discard if not used within 8 hours.)

 (MenACWY-D (Menactra)Ages:9 months and olderUse for: Any dose in the series (and certain high-risk groups)Route:Intramuscular (IM) injectionDo NOT Freeze)	 (MenACWY-TT (MenQuadfi)Ages:2 years and olderUse for:Any dose in the series (and certain                    high-risk groups)Route:Intramuscular (IM) injectionDo NOT Freeze)

 (Meningococcal Vaccines)

Intramuscular (IM) injection

**Route:**

**MenACWY-CRM (Menveo)**

**Single-Vial (Ready-to-Use)**

**Pink Cap Vial**

**Ages:**10 years and older

**Use for:**Any dose in the series 

**Do NOT Freeze**

**Ages:**2 months and older

**Use for:**Any dose in the series 

**MenACWY-CRM (Menveo)**

**Two-Vial (Reconstitution Required)**

**Orange Cap Vial (MenA)   Gray Cap Vial (CWY)**

**Route:**

Intramuscular (IM) injection

**Reconstitute the MenA lyophilized conjugate component ONLY with manufacturer-supplied MenCWY liquid conjugate component.**

**Do NOT administer MenCWY without MenA**

**Do NOT Freeze**

**Beyond Use Time: Use immediately after reconstitution. May be stored between**

**2° and 25°C (36° and 77°F) for up to 8 hours.**

 (Ages:MenB-4C (Bexsero)10 years and olderUse for: Any dose in the seriesRoute:Intramuscular (IM) injectionBexsero and Trumenba are NOT interchangeable Complete series with same vaccine product)

 (MenB-FHbp (Trumenba)Ages:10 years and olderUse for: Any dose in the seriesRoute:Intramuscular (IM) injectionBexsero and Trumenba are NOT interchangeable Complete series with same vaccine product)

Pneumococcal Vaccines

 (Route:) (Intramuscular (IM) injection ORSubcutaneous (subcut) injection) (PPSV23 (Pneumovax 23)Ages:      Persons aged 2 through 64 years with certain risk conditions or adults 65 years and older with indicationsUse for: After PCV15 dose) (PCV13 (Prevnar 13)Ages: Children 6 weeks through 5 yearsCertain high-risk groups 6 years through 18 years who have never received PCV13 or received an incomplete PCV13 seriesRoute: Intramuscular (IM) injection)
**Do NOT Freeze**

**Do NOT Freeze**

**Do NOT Freeze**

**PCV20 (Prevnar 20)**

**Ages:**6 weeks and older

**Use For:**Any dose in the series

**Route:**

Intramuscular (IM) injection

**Do NOT Freeze**

**PCV15 (Vaxneuvance)**

**Ages:**6 weeks and older

**Use For:**Any dose in the series

**Route:**

Intramuscular (IM) injection

Poliovirus Vaccine

**Ages:**

**IPV**

6 weeks and older

**Use for:**Any dose in the series

**Route:**

Intramuscular (IM) injection OR

Subcutaneous (subcut) injection

Rotavirus Vaccines

**RV1 (Rotarix)**

**Single Oral Applicator (Ready-to-use)**

**Ages:**6 weeks through 8 months, 0 days 

**Doses:** Two

Maximum age for 1st dose -14 weeks, 6 days

Maximum age for last dose - 8 months, 0 days

**Route:**Oral (PO)

**Do NOT Inject**

**Do NOT Freeze**

**RV1 (Rotarix)**

**Vial plus Oral Applicator**

****

**Ages:**6 weeks through 8 months, 0 days 

**Doses:**    Two 

               Maximum age for 1st dose - 14 weeks, 6 days 

               Maximum age for last dose - 8 months, 0 days

**Route:**Oral (PO)

**Reconstitute RV1 powder ONLY with manufacturer-supplied sterile water/calcium carbonate/xanthan diluent**

**Do NOT Inject**

**Do NOT Freeze**

**Beyond Use Time: If not used immediately after reconstitution, store at 2°C to 8°C (36°F to 46°F) or at controlled room temperature up to 25°C (77°F) and discard if not used within 24 hours.**

Rotavirus Vaccines

 (RV5 (RotaTeq)Ages: 6 weeks through 8 months, 0 days Doses: Two            Maximum age for 1st dose - 14 weeks, 6 days             Maximum age for last dose is 8 months, 0 daysRoute:Oral (PO)) (Do NOT inject)

Respiratory Syncytial Virus (RSV)
**RSV (GSK/AREXVY)**

**Ages:**60 years and older

**Route:**Intramuscular (IM) injection

**Reconstitute RSV powder ONLY with**

**manufacturer-supplied adjuvant suspension**

**Do Not Freeze**

**Beyond Use Time: If not used immediately after reconstitution, store refrigerated at 2°C to 8°C (36°F to 46°F) or at room temperature up to 25°C (77°F). Discard if not used within 4 hours.**

**RSV (Pfizer/ABRYSVO)**

**Ages:**60 years and older

	      Pregnant people at 32-36 weeks gestation

**Route:**Intramuscular (IM) injection

**Reconstitute RSV powder ONLY with**

**manufacturer-supplied sterile water diluent**

**Do Not Freeze**

**Beyond Use Time: If not used immediately after reconstitution, store at room temperature [15°C to 30°C (59°F to 86°F)] and discard if not used within 4 hours.**

Tetanus- and Diphtheria-Toxoid-Containing Vaccines

 (Ages:DT (generic)6 weeks through 6 yearsUse for: Primary series and booster dosesONLY for children with a contraindication or precaution to pertussis vaccineRoute:Intramuscular (IM) injection) (Ages:Td (generic)7 years and olderUse for: Primary series and booster dosesfor persons previously vaccinated with TdapRoute:Intramuscular (IM) injection) (Ages:Td (Tenivac)7 years and olderUse for: Primary series and booster dosesfor persons previously vaccinated with TdapRoute:Intramuscular (IM) injection)

Tetanus- and Diphtheria-Toxoid- and acellular Pertussis-Containing Vaccines

 (Tdap (Adacel)Ages:7 years and olderUse for:Routine adolescent dose at 11 to 12 years of ageEach pregnancyPatients not fully vaccinated for pertussisRoute:Intramuscular (IM) injection) (Tdap (Boostrix)Ages:7 years and olderUse for:Routine adolescent dose at 11 to 12 years of ageEach pregnancyPatients not fully vaccinated for pertussisRoute:Intramuscular (IM) injection)

# Frozen Varicella-Containing Vaccines

 (Ages:VAR (Varivax)12 months and olderUse for: Any dose in the seriesRoute:Subcutaneous (subcut) injectionReconstitute VAR powder ONLY withmanufacturer-supplied sterile water diluentBeyond Use Time: Discard reconstituted vaccine if not used within 30 minutes.) (Ages:MMRV (ProQuad)12 months through 12 yearsUse for: Any dose in the seriesRoute:Subcutaneous (subcut) injectionReconstitute MMRV powder ONLY withmanufacturer-supplied sterile water diluentBeyond Use Time: Discard reconstituted vaccine if not used within 30 minutes.)

Refrigerated Varicella-Containing Vaccine

**RZV (Shingrix)**

**Ages:**Adults 50 years and older

Adults****19 years and older who are or will be immunodeficient or immunosuppressed because of disease or therapy

**Use for:**Any dose in the series

**Route:**Intramuscular (IM) injection

**Refrigerate both components; do NOT freeze**

**Reconstitute lyophilized varicella zoster component with manufacturer-supplied adjuvant suspension**

**Beyond Use Time: Discard reconstituted vaccine if not used within 6 hours.**

 (DTaP-IPV/HIB (Pentacel)+=Lyophilized Hib Manufacturer’s DTaP- componentIPV liquid componentPentacel vaccineShould be used immediately after reconstitution)	 (Hib (ActHIB)+=LyophilizedHib componentManufacturer’s 0.4% sodium chloride diluentActHIB vaccineBeyond Use Time: If not used immediately after reconstitution, store at 2°C to 8°C (36°F to 46°F) and discard if not used within 24 hours.Should be shaken vigorously before injection.)

 (MMR (M-M-R II)+=LyophilizedManufacturer’sMMR component sterile water diluentM-M-R IIvaccineBeyond Use Time: If not used immediately after reconstitution, store in vaccine vial in dark place at 2°C to 8°C (36°F to 46°F) and discard if not used within 8 hours.) (Hib (Hiberix)+=Lyophilized HibManufacturer’s 0.9% componentsodium chloride diluentHiberix vaccineBeyond Use Time: If not used immediately after reconstitution, store at 2°C to 8°C (36°F to 46°F) and discard if not used within 24 hours.Should be shaken vigorously before injection.)

 (Reconstituted Vaccines)

 (MenACWY-CRM (Menveo)+LyophilizedMenA component=MenCWY liquid componentMenveo vaccineBeyond Use Time: Should be used immediately after reconstitution, but may be stored at or below 25°C (77°F) and discarded if not used within 8 hours.)

 (RV1 (Rotarix)+=Lyophilized RV1Manufacturer’s sterile water-componentcalcium carbonate-xanthan diluentRotarix vaccineDo NOT injectBeyond Use Time: If not used immediately after reconstitution,store at 2°C to 8°C (36°F to 46°F) or at controlled room temperature up to 25°C (77°F) and discard if not used within 24 hours.)

 (VAR (Varivax)+=Lyophilized VARManufacturer’s componentsterile water diluentVarivax vaccineBeyond Use Time: Discard reconstituted vaccine if not used within 30 minutes.)

 (MMRV (ProQuad)+Lyophilized MMRVcomponent=Manufacturer’ssterile water diluentProQuad vaccineBeyond Use Time: Discard reconstituted vaccine if not used within 30 minutes.) (RZV (Shingrix)+=Lyophilized varicellaManufacturer’szoster componentadjuvant suspensionShingrix vaccineRefrigerate both components; do NOT freezeBeyond Use Time: Discard reconstituted vaccine if not used within 6 hours.)

# image2.jpeg

# image3.jpeg

# image4.jpeg

# image5.png

# image6.png

# image7.png

# image8.png

# image9.png

# image10.png

# image11.jpeg

# image12.jpeg

# image13.jpeg

# image14.png

# image15.png

# image16.png

# image17.jpeg

# image18.jpeg

# image19.jpeg

# image20.jpeg

# image21.jpeg

# image22.jpeg

# image1.jpeg